NeuroBio

Curated by Signal

Provider of AI-powered platform for drug discovery

Overview

Provider of AI-powered platform for drug discovery. The company has an AI engine, "NeuroAI" a machine learning-based discovery engine to discover new small molecule medicines. It has a pipeline of drugs for the treatment of neurological diseases.

Key facts

Founded: 2022
Headquarters: Bethlehem, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

5 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Kailos
Provider of consumer-based genetic testing services
Life Sciences TechnologyHuntsville, United States
Dante Labs
Provider of whole-genome sequencing analysis for health and wellness
Life Sciences TechnologyNew York City, United States
Altimate
Provider of medical devices for neurological disease, and computational physics
Life Sciences TechnologyBoston, United States

About NeuroBio

What does NeuroBio do?

Provider of AI-powered platform for drug discovery.

Where is NeuroBio headquartered?

NeuroBio is headquartered in Bethlehem, United States.

When was NeuroBio founded?

NeuroBio was founded in 2022.

Which sector is NeuroBio in?

NeuroBio operates in Life Sciences Technology.

Who are NeuroBio's competitors?

Companies similar to NeuroBio include Kailos, Dante Labs, and Altimate.